| Sep 6 |
Bristol-Myers Still A Value Play Despite Appreciating 26.56% From 2024 Lows
|
| Sep 6 |
Implied Volatility Surging for Bristol-Myers (BMY) Stock Options
|
| Sep 6 |
Argenx (ARGX) Moves 4.0% Higher: Will This Strength Last?
|
| Sep 6 |
Bristol Myers Squibb Employees to Relay Nearly 3,000 Miles Cross-Country Aspiring to Raise Over $1 Million for the V Foundation for Cancer Research
|
| Sep 5 |
Bristol Myers Squibb (BMY) Falls More Steeply Than Broader Market: What Investors Need to Know
|
| Sep 5 |
Is Bristol-Myers Squibb Company (BMY) The Best Beaten Down Dividend Stocks to Invest in Now?
|
| Sep 5 |
Bristol-Myers Squibb Company (BMY) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
|
| Sep 4 |
Why Is Axsome (AXSM) Up 4.8% Since Last Earnings Report?
|
| Sep 3 |
US will still pay at least twice as much after negotiating drug prices
|
| Sep 2 |
2 Reasons Bristol Myers Squibb Stock Could Be a Bargain, Down 34% From Its All-Time High
|
